The major goal of the Neuropathology (NP) Core is to provide researchers with well characterized and preserved brain tissue and diagnostic neuropathology evaluations for Alzheimer's Disease (AD) patients and controls. Provision of such tissue is essential to the overall goal of the ADCC to promote strong scientific investigations of AD. In order to achieve this goal, the NP Core will carry out the following specific tasks: 1. obtain brain tissue from AD and control patients who have undergone multiple annual neuropsychological and neurological evaluations prior to death; 2. preserve the tissue in a variety of ways in order to allow application of the most up-to-date technologies by researchers; 3. apply standard criteria for the diagnosis of AD to these brains in a consistent fashion and provide a thorough neuropathological evaluation; 4. maintain an awareness of controversies and evolving standards in the diagnostic criteria; 3. store brain tissue and neuropathological data in a reliable way allowing rapid retrieval; and 6. encourage use of resources of the NP Core by researchers through tissue and data accessibility and accommodation of special preservation protocols. To improve access to well-studied control tissue, the ADCC has established the Religious Orders Study (ROS) Core. The NP Core has begun to obtain brain tissue (19 cases so far) from study subjects who have undergone careful neurological and neuropsychological follow-up. This tissue is likely to be especially valuable in making rigorous clinical- pathological correlations. The NP Core proposes to provide investigators with tissue from this a stereological quantitation of PHF-tau immunostained neuritic plaques and neurofibrillary tangles in the frontal, temporal, and parietal cortices, hippocampus, and entorhinal cortex of-tissue from the ROS core subjects, with the goals of further characterizing the interface between Alzheimer's disease and aging changes in the brain and evaluating stereologic technology as a potential tool to assist in diagnostic classification of this area.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
2P30AG010161-06
Application #
5204753
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
1996
Total Cost
Indirect Cost
Tasaki, Shinya; Gaiteri, Chris; Mostafavi, Sara et al. (2018) The Molecular and Neuropathological Consequences of Genetic Risk for Alzheimer's Dementia. Front Neurosci 12:699
Burke, Shanna L; Cadet, Tamara; Maddux, Marlaina (2018) Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc 110:314-325
Hanfelt, John J; Peng, Limin; Goldstein, Felicia C et al. (2018) Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center. Neurobiol Dis 117:62-71
Oveisgharan, Shahram; Arvanitakis, Zoe; Yu, Lei et al. (2018) Sex differences in Alzheimer's disease and common neuropathologies of aging. Acta Neuropathol 136:887-900
Guo, Caiwei; Jeong, Hyun-Hwan; Hsieh, Yi-Chen et al. (2018) Tau Activates Transposable Elements in Alzheimer's Disease. Cell Rep 23:2874-2880
Felsky, Daniel; Patrick, Ellis; Schneider, Julie A et al. (2018) Polygenic analysis of inflammatory disease variants and effects on microglia in the aging brain. Mol Neurodegener 13:38
Malek-Ahmadi, Michael; Chen, Kewei; Perez, Sylvia E et al. (2018) Cognitive composite score association with Alzheimer's disease plaque and tangle pathology. Alzheimers Res Ther 10:90
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826
Zhou, Zilu; Wang, Weixin; Wang, Li-San et al. (2018) Integrative DNA copy number detection and genotyping from sequencing and array-based platforms. Bioinformatics 34:2349-2355
Cheng, Hao; Xuan, Hongwen; Green, Christopher D et al. (2018) Repression of human and mouse brain inflammaging transcriptome by broad gene-body histone hyperacetylation. Proc Natl Acad Sci U S A 115:7611-7616

Showing the most recent 10 out of 786 publications